Who owns Coherus Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CHRS from SEC Form 13F filings across 146 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 146 institutions disclosed 70.3M shares of Coherus Oncology, Inc. worth $98.5M — about 45.4% of shares outstanding; the largest disclosed holder is Timothy G. Youngquist 2020 Irrevocable Trust. Source: SEC Form 13F filings, parsed by EvidInvest.
146
13F holders
$98.5M
value, 2026 filers
45.4%
of shares outstanding (70.3M sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CHRS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Timothy G. Youngquist 2020 Irrevocable TrustNEW | 13.1M | $18.3M | 3.6% | 8.4% | new |
| 2 | BlackRock, Inc. | 12.0M | $16.8M | 0.0% | 7.8% | +15.8% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 5.9M | $8.3M | 0.0% | 3.8% | +9.1% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 3.7M | $5.2M | 0.0% | 2.4% | +18.1% |
| 5 | SAMSARA BIOCAPITAL, LLC | 3.4M | $4.8M | 0.4% | 2.2% | 0.0% |
| 6 | Kohlberg Kravis Roberts & Co. L.P. | 3.0M | $4.2M | 0.1% | 2% | 0.0% |
| 7 | STATE STREET CORP | 2.4M | $3.3M | 0.0% | 1.5% | +2.4% |
| 8 | TWO SIGMA INVESTMENTS, LP | 2.3M | $3.2M | 0.0% | 1.5% | -1.9% |
| 9 | CM Management, LLC | 2.1M | $2.9M | 1.9% | 1.4% | 0.0% |
| 10 | C WorldWide Group Holding A/S | 1.9M | $2.7M | 0.1% | 1.2% | 0.0% |
| 11 | Alyeska Investment Group, L.P. | 1.7M | $2.4M | 0.0% | 1.1% | -23.0% |
| 12 | Hudson Bay Capital Management LP | 1.7M | $2.4M | 0.0% | 1.1% | -0.7% |
| 13 | AQR CAPITAL MANAGEMENT LLC | 1.3M | $1.9M | 0.0% | 0.9% | +10.3% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.2M | $1.7M | 0.0% | 0.8% | +6.2% |
| 15 | PANAGORA ASSET MANAGEMENT INC | 1.1M | $1.6M | 0.0% | 0.7% | -22.1% |
| 16 | NORTHERN TRUST CORP | 1.1M | $1.6M | 0.0% | 0.7% | +23.6% |
| 17 | VANGUARD FIDUCIARY TRUST CO | 1.0M | $1.4M | 0.0% | 0.7% | +7.0% |
| 18 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 899,999 | $1.3M | 0.0% | 0.6% | 0.0% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 883,454 | $1.2M | 0.0% | 0.6% | +46.1% |
| 20 | UBS Group AG | 760,358 | $1.1M | 0.0% | 0.5% | +39.0% |
| 21 | GOLDMAN SACHS GROUP INC | 602,075 | $842,905 | 0.0% | 0.4% | -13.5% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 563,056 | $788,278 | 0.0% | 0.4% | +69.7% |
| 23 | STRS OHIO | 395,600 | $553,840 | 0.0% | 0.3% | +22.1% |
| 24 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 391,000 | $547,400 | 0.0% | 0.3% | -11.3% |
| 25 | GSA CAPITAL PARTNERS LLP | 379,355 | $531,000 | 0.0% | 0.2% | +18.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.